Member Info for mateyboy

they have just done a placing and raised only half what hey wanted, feel the city isnt too keen to give more cash. hence the reason they laid off 60 percent plus of the work force

have the cash they just need to repay or come up with a deal to pay back, just means less to plough into the programme

another damp squib, had so much promise too :(

unfortunately we are led by the greedy and the stupid; as i get older i realise that so called "clever" people are actually pretty clueless, c'est le vie

60% percent have lost their jobs just last month

you are indeed correct, we need new drugs that operate via new modes of action, not old ones that bacteria is developing resistance too. Anything new will not be used willy nilly and only as a last line of defence, hence the reason no monies will be made from new drugs. one hopes we have learnt our lesson on over prescribing stuff

again no idea if AZ will also be interested in the oncology pipeline, one thing for certain they will need more cash to progress things on. best of british to them

i'd be very surprised if AZ are interested, they mothballed their anti bac program some time ago, but who knows. as most novel new leads are top isomerase 4 and dna gyrsae driven. different mode of action as apposed to the flurorquinolone's

yes on current drugs, plus i would say 14.5 billion for a global market is very much. there has not been a new anti bac drug for 30 years. the pace is now picking up but due to goverment funding a la carbx etc , not big pharma stumping up the money. are you a scientist do you work in the industry??

as i said "no in house" they will outsource that program to my knowledge no one has yet picked up the program. the carbx funding comes with the caveat that it has to be done, no work is being done by redx on anti bacs, weather it be gram neg or pos. as i said dyor

just to add no money in antibacs that is why no pharma are researching them :(

nope; do some research the stopped that so they could concentrate on the oncology/immunology part of the business. redx do not do any anti bac research now in house

unfortunately folk think they know better than those in the business, drug to market costs mutli millions of pounds and attrition is hugh.chances are slim no matter how much people harp on about the strength of the portfolio. REDX was supposed to get decent hits then sell on, they havnt done this and decided to go the whole hog. big risk. hope it comes off but chances are very slim indeed. AIMO of course

i believe there was a caveat that they should employ so many people for so long, with the redundancies they have also failed on this score too. costs a lot to take a drug to first time in man, redx have approx 15 mill (being generous) they now need to find 2 mill to pay back LCC. not great

yes many countries unethical when it comes to anti biotics, china and india being very bad indeed. we will eventually pay the price for this

hmm trying to work out who you are lol

i suggest you do some research on the net about getting drugs to market and how much it costs and what the attrition rate is

why do top pharma not do anti bac research, massive unmet need on this which will only get worse as resistance kills off all our current drugs. Could it be that there is no money to be made??

i agree with all you say: roperace, thanks for the back up. i worked for az for 15 years as a research scientist, i love those with way more knowledge than me ;)

my statement is fact- a big factor in what you say is that non smokers no longer passive smoke since the ban on smoking in public places. I agree in the next 20 years we should see a decline in certain types of cancers, all good for the health service. i also never said you would live longer by having a healthy life style but it certainly wont do you any harm. a classic tee shirts says "eat well, exercise, die anyway"